Epidemiology of mucormycosis in post-COVID-19 patients treated in a tertiary care hospital, Visakhapatnam, Andhra Pradesh

INTRODUCTION: Mucormycosis is associated with high mortality (45–90%) in average-income countries including India. Prevention of mucormycosis associated with coronavirus disease 2019 (COVID-19) or in patients recovering from COVID-19 needs a further understanding on epidemiology and underlying risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Manda, Venkata Vijayasekhar, Patruni, Manoj, Nagendra, MPA Babu, Bharthi, M. Swatantra, Nagappa, Vivek, Kurumella, Hema Swaroop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041281/
https://www.ncbi.nlm.nih.gov/pubmed/36993057
http://dx.doi.org/10.4103/jfmpc.jfmpc_935_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041281/
https://www.ncbi.nlm.nih.gov/pubmed/36993057
http://dx.doi.org/10.4103/jfmpc.jfmpc_935_22

Ejemplares similares